Stransky, Nicolas
Celsius Therapeutics,
United States
2025 Rank: 145042
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 4394 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 145042 | 166408 |
| Total Cites | 2428 | 2487 |
| H-index | 21 | 21 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 178 | 180 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 178 | 180 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2219 | 2271 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.10 |
| Self-Citation Percentage |
2.37%
|
|
Stransky, Nicolas
Celsius Therapeutics,
United States
2024 Rank: 128801
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 4190 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 128801 | 144811 |
| Total Cites | 2544 | 2609 |
| H-index | 21 | 22 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 186 | 187 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 186 | 187 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2313 | 2357 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.11 |
| Self-Citation Percentage |
2.49%
|
|
Stransky, Nicolas
Celsius Therapeutics,
United States
2023 Rank: 106932
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 3809 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106932 | 116281 |
| Total Cites | 3174 | 3282 |
| H-index | 21 | 22 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 249 | 254 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 249 | 254 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2822 | 2895 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.13 |
| Self-Citation Percentage |
3.29%
|
|
Stransky, Nicolas
Celsius Therapeutics,
United States
2022 Rank: 79206
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 3020 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79206 | 89990 |
| Total Cites | 3521 | 3657 |
| H-index | 22 | 23 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 287 | 292 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 287 | 292 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 3136 | 3232 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.13 |
| Self-Citation Percentage |
3.72%
|
|
Stransky, Nicolas
Broad Institute,
United States
2021 Rank: 100401
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 3569 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100401 | 114077 |
| Total Cites | 4928 | 5121 |
| H-index | 23 | 24 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 440 | 445 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 440 | 445 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 4429 | 4568 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
3.77%
|
|
Stransky, Nicolas
Broad Institute,
United States
2020 Rank: 81220
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 2842 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81220 | 90571 |
| Total Cites | 3586 | 3779 |
| H-index | 22 | 23 |
| Hm-index | 1 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 375 | 382 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 375 | 382 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 3242 | 3382 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
5.11%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.